News and Announcements
Full House for the First Small Cap Showcase
- Published March 09, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Events
Yesterday, Wholesale Investor hosted its Sydney Small Cap Showcase for 2017. The atmosphere was electric with 180 attendees as well as over 150 viewers online with this being our first event live-streaming!
The event featured 10 emerging growth companies, all featuring on the ASX. Special guest speaker James Spenceley, CEO of MHOR Asset Management, kicked of the session by highlighting the themes of interest to MHOR and examples of some of their investments.
Domenic Carosa the CEO of Crowd Mobile (ASX:CM8) spoke about the power of “influencer marketing” on social media platforms is replacing the 30 second adverts and the CEO, Executive Director and Founder, Dr. Catriona Wallace from Cre8tek (ASX:CR8) highlighted the role AI can play in online marketing, sales and customer support. Collaborate (ASX:CM8) CEO Chris Noone discussed the value created in the collaboration and sharing economy along with how their investments in the likes Drive My Car are experiencing high growth, through deals with Uber, Subaru and Orix.
We thank the investors who joined us and the CEO’s which presented. At the end of each event, we are humbled by the innovation, persistence and ambition of our clients.
Our next events will be based in Melbourne, Sydney and Singapore, scheduled for mid-late March 2017. Click on the button below to find out more about our upcoming events or to register.
Events
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
